ESTI 2024 Rome

We have the honour and the pleasure to invite you to the ESTI 2024 Annual Scientific Meeting. After a successful meeting in Oxford 2022 and Berlin 2023, we are looking forward to offer you again attractive and interesting opportunities to become part of this subspecialty congress. Various options within an exciting scientific & educational programme focusing on chest and thoracic imaging shall help to perfectly position your company and reach about 650 expected international participants.

 

Main topics 2024

The scientific programme will focus on all the aspects of Thoracic Imaging, offering lectures on state-of-the-art CT, MRI, and interventional radiology, together with scientific presentations detailing the latest technical and diagnostic advancements in our field. With imaging playing a central role in diagnosis and therapy control, we aim to build a bridge between clinicians, radiologists, and industry, thus eliciting interdisciplinary discussion, teaching, and information sharing. We will delve into topics such as lung fibrosis, lung cancer screening and staging, response evaluation criteria to targeted and immuno-oncology therapies, lung infections, chronic obstructive pulmonary disease, pulmonary hypertension, and the burgeoning role of artificial intelligence in chest disease diagnosis and quantification. Multidisciplinary sessions, industry sponsored lunch symposia and slots devoted to specific topics are intended to be promoted.

 

Supporting ESTI 2024 Rome – What’s in for the industry?

– Participate and present your products and research in the exhibition to an international audience
– Stimulate and discuss new research: Use the unique debates concept to stir discussion and create awareness
– Encourage and promote education and public awareness
– Cooperate and network with opinion leaders
– Support and assist opinion leaders to reach the best clinical recommendations for current therapeutic dilemmas
– Inform and update international participants on clinical and technological developments

 

The industry partners are the most important supporters of ESTI, enabling us to organise such great meetings and to keep the high quality and standard of our events. In return, ESTI would like to offer various different options of a possible cooperation enlisted in the sponsor options brochure.

Besides our standard options, we will be happy to create your very own sponsor package or discuss further options that might be interesting to your company. We would be delighted to welcome you as a partner of the ESTI 2024 Rome congress.

If you are interested, please send an email to the ESTI Office (office@myESTI.org).

AIFA authorization process for pharmaceutical companies

AIFA – Requests for authorisation of conferences and meetings in Italy
https://www.aifa.gov.it/en/web/guest/acc

Any Italian or foreign marketing authorisation holder (or company engaged in the marketing of pharmaceuticals based on an agreement with the respective MAH), wishing to organise or participate in the organisation of a conference or a meeting on topics related to the use of pharmaceuticals, should submit to AIFA a request for authorisation of a proposed conference or meeting, whose technical nature will be then assessed by AIFA.
This is in line with article 124 of Italian legislative decree 219/2006.

 

As per paragraph 2, we have chosen the following partner
Atlante Viaggi Italia Srl
Via Bandello, 1
20123 Milano
Barbara.Mantegazza@atlanteviaggi.com

 

As per Italian law,
the AIFA authorization is necessary

  • for each pharmaceutical company (with Marketing Authorization Holder or the companies responsible for the actual marketing of pharmaceutical products) sponsoring the congress on topics in any way related to the use of its own pharmaceutical products.

The AIFA authorization is not necessary

  • when a company promotes by advertising only medical devices or food supplements during a congress (products without Marketing Authorization)
  • when a company sponsors a meeting about topics not related to the use of any of its own medicinal products; in this case the company is not allowed to expose or distribute any kind of advertising material during the meeting (Section 9 art. 124 D.L. n.219/06)

 

Any pharmaceutical company that sponsors a congress on topics related to the use of its pharmaceutical products, must apply to the competent unit of the Italian Medicines Agency (AIFA) to obtain a specific authorization. If your pharmaceutical company has a marketing authorization (MAH or AIC) or the companies responsible for the effective marketing of your pharmaceutical products and sponsor the congress on topics related to the use of your pharmaceutical products, you should contact Atlante Viaggi communicating your SIS code, by 23 February: barbara.mantegazza@atlanteviaggi.com.

 

If you don’t have a SIS code yet, we recommend that you contact your Italian branch, your regulatory office or your representative in Italy as soon as possible, to start the procedure to obtain the SIS code necessary to be included in the procedure by 23 February or have more information on Italian legislation.

ESTI 2024 Partners

We thank our industry partners 2024 for their valuable support!

                 

X